These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 23920875

  • 21. The state of dietary supplement adverse event reporting in the United States.
    Gardiner P, Sarma DN, Low Dog T, Barrett ML, Chavez ML, Ko R, Mahady GB, Marles RJ, Pellicore LS, Giancaspro GI.
    Pharmacoepidemiol Drug Saf; 2008 Oct; 17(10):962-70. PubMed ID: 18613260
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Drug-versus-drug adverse event rate comparisons: a pilot study based on data from the US FDA Adverse Event Reporting System.
    Hochberg AM, Pearson RK, O'Hara DJ, Reisinger SJ.
    Drug Saf; 2009 Oct; 32(2):137-46. PubMed ID: 19236120
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Atypical antipsychotic drugs and diabetes mellitus in the US Food and Drug Administration Adverse Event database: a systematic Bayesian signal detection analysis.
    Baker RA, Pikalov A, Tran QV, Kremenets T, Arani RB, Doraiswamy PM.
    Psychopharmacol Bull; 2009 Oct; 42(1):11-31. PubMed ID: 19204649
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Prospective data mining of six products in the US FDA Adverse Event Reporting System: disposition of events identified and impact on product safety profiles.
    Bailey S, Singh A, Azadian R, Huber P, Blum M.
    Drug Saf; 2010 Feb 01; 33(2):139-46. PubMed ID: 20082540
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Platinum agent-induced hypersensitivity reactions: data mining of the public version of the FDA adverse event reporting system, AERS.
    Sakaeda T, Kadoyama K, Yabuuchi H, Niijima S, Seki K, Shiraishi Y, Okuno Y.
    Int J Med Sci; 2011 Feb 01; 8(4):332-8. PubMed ID: 21611115
    [Abstract] [Full Text] [Related]

  • 31. Endotoxin-like reactions with intravenous gentamicin: results from pharmacovigilance tools under investigation.
    Hauben M, Reich L.
    Infect Control Hosp Epidemiol; 2005 Apr 01; 26(4):391-4. PubMed ID: 15865275
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Adverse event profile of tigecycline: data mining of the public version of the U.S. Food and Drug Administration adverse event reporting system.
    Kadoyama K, Sakaeda T, Tamon A, Okuno Y.
    Biol Pharm Bull; 2012 Apr 01; 35(6):967-70. PubMed ID: 22687540
    [Abstract] [Full Text] [Related]

  • 39. Data mining for signal detection of adverse events for taxanes based on the food and drug administration adverse drug events reporting system database.
    Wang LY, Liao LF, Lei CL, Wu Q, Guo YJ, Li Y.
    Expert Opin Drug Saf; 2023 Apr 01; 22(9):833-839. PubMed ID: 37055919
    [Abstract] [Full Text] [Related]

  • 40. Time-to-signal comparison for drug safety data-mining algorithms vs. traditional signaling criteria.
    Hochberg AM, Hauben M.
    Clin Pharmacol Ther; 2009 Jun 01; 85(6):600-6. PubMed ID: 19322165
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.